Fischer Medical Ventures Intrinsic Value
Fischer Medical Ventures (FISCHER) median intrinsic value is ₹44.50 from 8 valuation models (range ₹12–₹80), vs current price ₹40.13 — +10.9% upside (Trading Below Median Value), margin of safety 9.8%. For current market price and key ratios, visit Fischer Medical Ventures share price chart.
FISCHER Valuation Methods Summary — DCF, Graham Number & P/E
Fischer Medical Ventures intrinsic value across 8 models vs current price ₹40.13 — upside/downside and value range per method. Browse FISCHER complete financial for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹12.04 | ₹9.63 - ₹14.45 | -70.0% | EPS: ₹0.88, Sector P/E: 12x |
| Book Value Method | asset | ₹52.81 | ₹47.53 - ₹58.09 | +31.6% | Book Value/Share: ₹52.81, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹44.50 | ₹40.05 - ₹48.95 | +10.9% | Revenue/Share: ₹55.62, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹71.25 | ₹64.12 - ₹78.38 | +77.5% | EBITDA: ₹76.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹12.04 | ₹10.84 - ₹13.24 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹12.04 | ₹10.84 - ₹13.24 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹80.26 | ₹72.23 - ₹88.29 | +100.0% | ROE: 16.6%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹32.34 | ₹29.11 - ₹35.57 | -19.4% | EPS: ₹0.88, BVPS: ₹52.81 |
FISCHER Intrinsic Value vs Market Price — All Valuation Models
Fischer Medical Ventures fair value range ₹12–₹80 vs current market price ₹40.13 across 8 valuation models. Compare with FISCHER fair price to assess whether the stock is under or overvalued.
FISCHER Intrinsic Value Analysis — Undervalued or Overvalued?
Fischer Medical Ventures median intrinsic value ₹44.50, current price ₹40.13 — Trading Below Median Value by 10.9%, margin of safety 9.8%.
What is the intrinsic value of FISCHER?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Fischer Medical Ventures (FISCHER) is ₹44.50 (median value). With the current market price of ₹40.13, this represents a +10.9% variance from our estimated fair value.
The valuation range spans from ₹12.04 to ₹80.26, indicating ₹12.04 - ₹80.26.
Is FISCHER undervalued or overvalued?
Based on our multi-method analysis, Fischer Medical Ventures (FISCHER) appears to be trading below median value by approximately 10.9%.
FISCHER Financial Health — Key Ratios vs Industry Benchmarks
Fischer Medical Ventures financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 20.28 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 16.6% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 19.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.78x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
FISCHER Cash Flow Quality — Operating & Free Cash Flow
Fischer Medical Ventures operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-87 Cr | ₹-150 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-7 Cr | ₹-22 Cr | Negative Cash Flow | 3/10 |